SI1694271T1 - Fsh glikozilacijska mutanta - Google Patents

Fsh glikozilacijska mutanta

Info

Publication number
SI1694271T1
SI1694271T1 SI200431701T SI200431701T SI1694271T1 SI 1694271 T1 SI1694271 T1 SI 1694271T1 SI 200431701 T SI200431701 T SI 200431701T SI 200431701 T SI200431701 T SI 200431701T SI 1694271 T1 SI1694271 T1 SI 1694271T1
Authority
SI
Slovenia
Prior art keywords
fsh
glycosylation mutant
mutant
fsh glycosylation
lifes
Prior art date
Application number
SI200431701T
Other languages
English (en)
Inventor
Louise M Garone
Stephen J Arkinstall
William H Brondyk
Robert K Campbell
Xuliang Jiang
Sean D Mckenna
Mark Tepper
Original Assignee
Merck Serono Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Serono Sa filed Critical Merck Serono Sa
Publication of SI1694271T1 publication Critical patent/SI1694271T1/sl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/59—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g.hCG [human chorionic gonadotropin]; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Endocrinology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Reproductive Health (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
SI200431701T 2003-09-02 2004-09-02 Fsh glikozilacijska mutanta SI1694271T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US49980203P 2003-09-02 2003-09-02
EP04783331A EP1694271B1 (en) 2003-09-02 2004-09-02 Fsh glycosylation mutant
PCT/US2004/029042 WO2005020934A2 (en) 2003-09-02 2004-09-02 Fsh glycosylation mutant

Publications (1)

Publication Number Publication Date
SI1694271T1 true SI1694271T1 (sl) 2011-08-31

Family

ID=34272871

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200431701T SI1694271T1 (sl) 2003-09-02 2004-09-02 Fsh glikozilacijska mutanta

Country Status (24)

Country Link
US (1) US7700112B2 (sl)
EP (1) EP1694271B1 (sl)
JP (1) JP4653090B2 (sl)
KR (1) KR101099809B1 (sl)
CN (1) CN1984926B (sl)
AT (1) ATE511829T1 (sl)
AU (1) AU2004268683B2 (sl)
BR (1) BRPI0413206A (sl)
CA (1) CA2535522A1 (sl)
CY (1) CY1112439T1 (sl)
DK (1) DK1694271T3 (sl)
EA (1) EA012175B1 (sl)
ES (1) ES2367784T3 (sl)
HK (1) HK1101315A1 (sl)
HR (1) HRP20110430T1 (sl)
IL (1) IL174037A0 (sl)
MX (1) MXPA06002119A (sl)
NO (1) NO20061446L (sl)
PL (1) PL1694271T3 (sl)
PT (1) PT1694271E (sl)
SI (1) SI1694271T1 (sl)
UA (1) UA88879C2 (sl)
WO (1) WO2005020934A2 (sl)
ZA (1) ZA200601803B (sl)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080219952A1 (en) 2005-08-26 2008-09-11 Ares Trading S.A. Process For the Preparation of Glycosylated Interferon Beta
EP1960419B1 (en) * 2005-12-09 2016-03-16 Ares Trading S.A. Method for purifying fsh or a fsh mutant
EA013975B1 (ru) 2005-12-22 2010-08-30 Мерк Сероно С.А. Мутантный fsh и способы его применения
AU2007207697B2 (en) 2006-01-17 2012-01-19 Merck Serono Sa Novel FSH glycosylation variant D3N
DK2125899T3 (da) * 2007-03-26 2013-02-11 Novartis Ag Biomarkører til forudsigelse af renal sikkerhed samt biomarkørsignaturer til overvågning af nyrefunktion
AR081755A1 (es) 2010-04-02 2012-10-17 Hanmi Holdings Co Ltd Formulacion de accion prolongada de la hormona estimuladora de los foliculos donde se usa un fragmento de inmunoglobulina, metodo de preparacion y metodo para tratar a un sujeto que sufre un trastorno reproductivo
CN108676096B (zh) * 2018-05-22 2022-03-29 北京伟杰信生物科技有限公司 重组猪fsh-ctp融合蛋白及其制备方法与应用
CA3160345A1 (en) * 2019-11-06 2021-05-14 The Regents Of The University Of Colorado, A Body Corporate Modified follicle-stimulating hormone and methods of using the same

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4840896A (en) * 1983-11-02 1989-06-20 Integrated Genetics, Inc. Heteropolymeric protein
US4923805A (en) * 1983-11-02 1990-05-08 Integrated Genetics, Inc. Fsh
US5156957A (en) * 1983-11-02 1992-10-20 Genzyme Corporation Follicle stimulating hormone
US5639639A (en) * 1983-11-02 1997-06-17 Genzyme Corporation Recombinant heterodimeric human fertility hormones, and methods, cells, vectors and DNA for the production thereof
US4845077A (en) * 1984-04-03 1989-07-04 Serono Laboratories, Inc. Method of inducing ovulation
US4589402A (en) * 1984-07-26 1986-05-20 Serono Laboratories, Inc. Method of in vitro fertilization
JP3045539B2 (ja) * 1989-02-21 2000-05-29 ワシントン ユニバーシティ 改変型生殖ホルモン
US5338835A (en) * 1989-02-21 1994-08-16 Washington University CTP-extended form of FSH
US5508261A (en) * 1991-06-18 1996-04-16 University Of Medicine & Dentistry Of New Jersey Analogs of glycoprotein hormones having altered receptor binding specificity and activity and methods for preparing and using same
US6407205B1 (en) * 1997-06-04 2002-06-18 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College FSH-releasing peptides
ES2247710T3 (es) * 1997-06-20 2006-03-01 Akzo Nobel N.V. Antagonista de gonadotropina.
ATE329911T1 (de) * 1998-08-07 2006-07-15 Applied Research Systems Fsh mimetika zur behandlung von infertilität
PT1250148E (pt) * 2000-01-27 2004-09-30 Applied Research Systems Uso de fsh para o tratamento da infertilidade
US20020127652A1 (en) * 2000-02-11 2002-09-12 Schambye Hans Thalsgard Follicle stimulating hormones
WO2001058493A1 (en) * 2000-02-11 2001-08-16 Maxygen Aps Conjugates of follicle stimulating hormones
EP1487479B1 (en) * 2001-10-22 2012-06-20 Merck Serono SA Mutant glycoproteins

Also Published As

Publication number Publication date
UA88879C2 (en) 2009-12-10
WO2005020934A3 (en) 2007-02-15
MXPA06002119A (es) 2006-05-31
KR20070029620A (ko) 2007-03-14
BRPI0413206A (pt) 2006-10-03
CN1984926A (zh) 2007-06-20
EP1694271A2 (en) 2006-08-30
PL1694271T3 (pl) 2011-11-30
IL174037A0 (en) 2006-08-01
WO2005020934A2 (en) 2005-03-10
KR101099809B1 (ko) 2011-12-27
CN1984926B (zh) 2012-04-11
EA200600526A1 (ru) 2007-04-27
US7700112B2 (en) 2010-04-20
ES2367784T3 (es) 2011-11-08
AU2004268683A2 (en) 2005-03-10
DK1694271T3 (da) 2011-09-12
ZA200601803B (en) 2007-05-30
PT1694271E (pt) 2011-07-07
EP1694271B1 (en) 2011-06-08
AU2004268683B2 (en) 2010-06-24
ATE511829T1 (de) 2011-06-15
US20050100989A1 (en) 2005-05-12
CY1112439T1 (el) 2015-12-09
NO20061446L (no) 2006-03-30
HK1101315A1 (en) 2007-10-12
CA2535522A1 (en) 2005-03-10
AU2004268683A1 (en) 2005-03-10
JP2007508245A (ja) 2007-04-05
EA012175B1 (ru) 2009-08-28
HRP20110430T1 (hr) 2011-07-31
JP4653090B2 (ja) 2011-03-16

Similar Documents

Publication Publication Date Title
CY1112439T1 (el) Μεταλλαγμα fsh-γλυκοζυλιωσης
AU2003272536A8 (en) Use of a human amniotic membrane composition for prophylaxis and treatment of diseases and conditions of the eye and skin
AU2003264282A1 (en) Phenethanolamine derivatives and their use in the treatment of respiratory diseases
GB0001309D0 (en) Valve arrangement
AU4346401A (en) Human cord blood as a source of neural tissue for repair of the brain and spinalcord
EP1536834A4 (en) DESIGN OF CHEMOKINE ANALOGS FOR THE TREATMENT OF HUMAN DISEASES
HK1022651A1 (en) The use of levobupivacaine in facial surgery
EA200870177A1 (ru) Новый гликозилированный вариант fsh d3n
WO2002076313A8 (fr) Extenseur de l'os maxillaire
UA93893C2 (en) Fsh mutants
WO2004050679A3 (en) Mutant glycoproteins
GB0317453D0 (en) Method of producing a manufactured article in silk indicated in the treatment of some skin diseases of the human body
HUT63441A (en) Megakariocyte colony stimultating factor protein
AU2003281257A8 (en) A novel use of rapamycin and structural analogues thereof
WO2003042778A3 (en) Method for reordering custom-fitted apparel
USD467344S1 (en) Treatment couch
GB0202410D0 (en) Treatment of IL deficiencies
CN2345194Y (zh) 一种扣叩器
AU2003232356A1 (en) Improved baby garment
AU2002364889A8 (en) Methods for diagnosis and treatment of diseases associated with altered expression of nrf2
USD519640S1 (en) Apparatus for fitness treatments of human body
ATE95995T1 (de) Ergonomisches kopfkissen, insbesondere zur verhuetung und/oder behandlung von nackenbeschwerden.
GR990100106A (el) Οργανο παθητικης κινησιοθεραπειας σε ορθια θεση για ατομα με αναπηρια στα κατω ακρα
CA102676S (en) Cot
UA28676A (uk) Спосіб підготовки хворого до стоматологічного втручання